학술논문
A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT).
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p217-217, 9p
Subject
Language
ISSN
0732183X